STOCK TITAN

Bio-Techne Announces ISO 14001:2015 Certification for the EMEA region of Bio-Techne.

Rhea-AI Impact
(No impact)
Rhea-AI Sentiment
(Very Positive)
Tags

MINNEAPOLIS, Feb. 25, 2021 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH), a leading provider of proteins, antibodies and cytokines today announced that its sites in Abingdon, Langley, Rennes and Wiesbaden received ISO 14001:2015 certification for Environmental Management Systems. These Bio-Techne facilities provide Sales, Marketing, Purchasing, Order Processing, Warehousing, Distribution and Customer Services for the EMEA region.

ISO 14001 is an internationally recognized standard intended to provide a framework for companies to protect the environment and respond to changing environmental conditions. This achievement provides assurances to our customers that Bio-Techne is striving to contribute to the environmental pillar of sustainability.

"The EMEA team worked hard to become ISO 14001:2015 compliant and the certification is quite an achievement," said Dave Eansor, President Protein Sciences. "This certification reflects Bio-Techne's focus on minimizing its environmental impacts and I am very pleased with the team."

"I am proud of the EMEA team on this important accomplishment," said Kim Kelderman, President Genomics and Diagnostics. "Achieving ISO:14001:2015 compliance shows Bio-Techne's dedication to ongoing enhancement of our environmental performance."

"Environmental management is an integral core value and a vital part of Bio-Techne's culture," commented Chuck Kummeth, President and Chief Executive Officer of Bio-Techne.  "This achievement is another milestone in our continuous drive toward sustainability."

About Bio-Techne Corporation (NASDAQ: TECH)

Contact:

David Clair, Senior Director, Corporate Development


david.clair@bio-techne.com


612-656-4416

 

Bio-Techne

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/bio-techne-announces-iso-140012015-certification-for-the-emea-region-of-bio-techne-301235378.html

SOURCE Bio-Techne Corporation

Bio-Techne Corporation

NASDAQ:TECH

TECH Rankings

TECH Latest News

TECH Stock Data

13.16B
155.39M
0.97%
100.54%
3.39%
Biological Product (except Diagnostic) Manufacturing
Manufacturing
Link
United States of America
MINNEAPOLIS

About TECH

bio-techne (formerly techne corp.), nasdaq: tech, is a global life sciences company providing innovative bioactive tools and resources for the research and clinical diagnostic communities. bio-techne products assist scientific investigations into biological processes and the nature and progress of specific diseases. they aid in drug discovery efforts and provide the means for accurate clinical tests and diagnoses. with over 275,000 products in its portfolio, bio-techne generated approximately $358 million in net sales in fy 2014 and has over 1,000 employees worldwide.